A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Status:
Recruiting
Trial end date:
2031-08-05
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the long-term safety of avacopan in
participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).